| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |